Lung cancer screening update.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 2797473)

Published in Cancer Imaging on October 02, 2009

Authors

Massimo Bellomi1, Cristiano Rampinelli, Elvio De Fiori, Lorenzo Preda, Giulia Veronesi

Author Affiliations

1: Diagnostic Radiology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. massimo.bellomi@ieo.it

Articles cited by this

Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med (2006) 19.06

Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet (1999) 13.67

Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology (2005) 9.83

Computed tomography screening and lung cancer outcomes. JAMA (2007) 8.01

Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet (1998) 6.09

Lung cancer screening with CT: Mayo Clinic experience. Radiology (2003) 4.72

CT screening for lung cancer: five-year prospective experience. Radiology (2005) 4.33

CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol (2002) 3.41

Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet (2003) 2.95

Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology (2007) 2.91

Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer (2007) 2.85

Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology (2008) 2.37

Lung nodule enhancement at CT: multicenter study. Radiology (2000) 2.32

The effect of surgical treatment on survival from early lung cancer. Implications for screening. Chest (1992) 2.09

CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology (2004) 1.71

Mean sojourn time and effectiveness of mortality reduction for lung cancer screening with computed tomography. Int J Cancer (2008) 1.54

Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT. AJR Am J Roentgenol (2006) 1.53

Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. Lung Cancer (2008) 1.45

Radiological examination for peripheral lung cancers and benign nodules less than 10 mm. Lung Cancer (2003) 1.43

Lung cancer: interobserver agreement on interpretation of pulmonary findings at low-dose CT screening. Radiology (2007) 1.32

Limitations of screening for lung cancer with low-dose spiral computed tomography. Clin Cancer Res (2005) 1.15

Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program. J Thorac Cardiovasc Surg (2008) 1.14

CT of the chest: minimal tube current required for good image quality with the least radiation dose. AJR Am J Roentgenol (1995) 1.09

Primary prevention, smoking, and smoking cessation: implications for future trends in lung cancer prevention. Cancer (2000) 1.04

Pathologic and molecular features of screening low-dose computed tomography (LDCT)-detected lung cancer: a baseline and 2-year repeat study. Lung Cancer (2008) 0.97

Evolution of lung nodules < or =5 mm detected with low-dose CT in asymptomatic smokers. Br J Radiol (2007) 0.93

In vivo repeatability of automated volume calculations of small pulmonary nodules with CT. AJR Am J Roentgenol (2009) 0.92

Multi-slice computed tomography as a screening tool for colon cancer, lung cancer and coronary artery disease. Eur Radiol (2001) 0.89

Articles by these authors

Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Ann Intern Med (2012) 3.27

Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet (2003) 2.95

Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology (2007) 2.22

Imaging of lung hamartomas by multidetector computed tomography and positron emission tomography. Ann Thorac Surg (2008) 2.14

Lung cancer risk prediction to select smokers for screening CT--a model based on the Italian COSMOS trial. Cancer Prev Res (Phila) (2011) 1.98

Robotic lobectomy for non-small cell lung cancer (NSCLC): long-term oncologic results. J Thorac Cardiovasc Surg (2011) 1.94

Superior vena cava replacement for lung cancer using a heterologous (bovine) prosthesis: preliminary results. J Thorac Cardiovasc Surg (2006) 1.93

A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med (2011) 1.83

Oligometastatic non-small cell lung cancer: a multidisciplinary approach in the positron emission tomographic scan era. Ann Thorac Surg (2007) 1.63

Review article: pulmonary sarcomatoid carcinomas: a practical overview. Int J Surg Pathol (2009) 1.61

Anomalous segmental vein for right upper lobe: an unusual anatomical variation. Ann Thorac Surg (2002) 1.60

Superior vena cava resection for lung and mediastinal malignancies: a single-center experience with 70 cases. Ann Thorac Surg (2007) 1.50

Computed tomography-guided preoperative radiotracer localization of nonpalpable lung nodules. Ann Thorac Surg (2010) 1.48

Modulation of epidermal growth factor receptor status by chemotherapy in patients with locally advanced non-small-cell lung cancer is rare. J Clin Oncol (2004) 1.48

Evolution of emphysema in relation to smoking. Eur Radiol (2009) 1.47

Axillary radiotherapy instead of axillary dissection: a randomized trial. Italian Oncological Senology Group. Ann Surg Oncol (2002) 1.46

Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. Lung Cancer (2008) 1.45

Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results. Invest Radiol (2011) 1.39

Robotic anatomic segmentectomy of the lung: technical aspects and initial results. Ann Thorac Surg (2012) 1.26

Extended pneumonectomy with partial resection of the left atrium, without cardiopulmonary bypass, for lung cancer. Ann Thorac Surg (2005) 1.25

Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program. J Thorac Cardiovasc Surg (2008) 1.14

Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Cancer (2005) 1.10

Solid-liquid iron partitioning in Earth's deep mantle. Nature (2012) 1.10

Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancer. Anticancer Drugs (2006) 1.09

Immunhistochemistry by means of widely agreed-upon markers (cytokeratins 5/6 and 7, p63, thyroid transcription factor-1, and vimentin) on small biopsies of non-small cell lung cancer effectively parallels the corresponding profiling and eventual diagnoses on surgical specimens. J Thorac Oncol (2011) 1.07

A 10-year single-center experience on 708 lung metastasectomies: the evidence of the "international registry of lung metastases". J Thorac Oncol (2011) 1.06

Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors. PLoS One (2010) 1.04

Role of positron emission tomography scanning in the management of lung nodules detected at baseline computed tomography screening. Ann Thorac Surg (2007) 1.03

K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung. Mod Pathol (2004) 1.01

Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells. Cancer Res (2004) 1.00

Perfusion computed tomography for monitoring induction chemotherapy in patients with squamous cell carcinoma of the upper aerodigestive tract: correlation between changes in tumor perfusion and tumor volume. J Comput Assist Tomogr (2009) 0.99

Dual role of RASSF1 as a tumor suppressor and an oncogene in neuroendocrine tumors of the lung. Anticancer Res (2010) 0.98

Pathologic and molecular features of screening low-dose computed tomography (LDCT)-detected lung cancer: a baseline and 2-year repeat study. Lung Cancer (2008) 0.97

Radical en bloc resection for lung cancer invading the spine. J Thorac Cardiovasc Surg (2002) 0.95

Metronomic chemotherapy combined with bevacizumab and erlotinib in patients with metastatic HER2-negative breast cancer: clinical and biological activity. Clin Breast Cancer (2012) 0.94

Increased perioperative N-terminal pro-B-type natriuretic peptide levels predict atrial fibrillation after thoracic surgery for lung cancer. Circulation (2007) 0.94

3q26 Amplification and polysomy of chromosome 3 in squamous cell lesions of the lung: a fluorescence in situ hybridization study. Clin Cancer Res (2007) 0.94

The impact of preoperative body mass index on respiratory complications after pneumonectomy for non-small-cell lung cancer. Results from a series of 154 consecutive standard pneumonectomies. Eur J Cardiothorac Surg (2010) 0.93

The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis. Int J Biol Markers (2009) 0.93

In vivo repeatability of automated volume calculations of small pulmonary nodules with CT. AJR Am J Roentgenol (2009) 0.92

Diagnostic performance of low-dose computed tomography screening for lung cancer over five years. J Thorac Oncol (2014) 0.91

Titanium dioxide nanoparticle impact and translocation through ex vivo, in vivo and in vitro gut epithelia. Part Fibre Toxicol (2014) 0.91

Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer. Acta Oncol (2013) 0.91

Extended pneumonectomy for non-small cell lung cancer: morbidity, mortality, and long-term results. J Thorac Cardiovasc Surg (2007) 0.90

Impact of limited pulmonary function on the management of resectable lung cancer. Lung Cancer (2003) 0.89

Giant alveolar adenoma causing severe dyspnoea. J Thorac Oncol (2010) 0.88

Screening-detected lung cancers: is systematic nodal dissection always essential? J Thorac Oncol (2011) 0.87

Early stage gastric diffuse large B-cell lymphomas: results of a randomized trial comparing chemotherapy alone versus chemotherapy + involved field radiotherapy. (IELSG 4). [corrected]. Leuk Lymphoma (2009) 0.87

Extrapulmonary malignancies detected at lung cancer screening. Radiology (2011) 0.87

Phase ib of sorafenib in combination with everolimus in patients with advanced solid tumors, selected on the basis of molecular targets. Oncologist (2014) 0.86

A quantitative method for estimating individual lung cancer risk. Acad Radiol (2010) 0.86

Endoscopic ultrasound and Computed Tomography in gastric stromal tumours. Radiol Med (2002) 0.85

Nutrient intake and nutrient patterns and risk of lung cancer among heavy smokers: results from the COSMOS screening study with annual low-dose CT. Eur J Epidemiol (2013) 0.85

CD117 immunoreactivity in high-grade neuroendocrine tumors of the lung: a comparative study of 39 large-cell neuroendocrine carcinomas and 27 surgically resected small-cell carcinomas. Virchows Arch (2004) 0.84

Budesonide versus placebo in high-risk population with screen-detected lung nodules: rationale, design and methodology. Contemp Clin Trials (2010) 0.83

X-Ray absorption studies of Zn2+ binding sites in bacterial, avian, and bovine cytochrome bc1 complexes. Biophys J (2007) 0.83

Efficacy of microdrainage in severe subcutaneous emphysema. Chest (2002) 0.83

Robotic Nipple-sparing Mastectomy and Immediate Breast Reconstruction With Implant: First Report of Surgical Technique. Ann Surg (2015) 0.83

Vaccines in non-small cell lung cancer: rationale, combination strategies and update on clinical trials. Crit Rev Oncol Hematol (2012) 0.83

The rate of incidental findings in lung cancer screening trials is not negligible. Eur Radiol (2007) 0.83

Comparative uptake and impact of TiO₂ nanoparticles in wheat and rapeseed. J Toxicol Environ Health A (2012) 0.82

Evaluation of the response to therapy of neoplastic lesions. Radiol Med (2004) 0.82

Which factors affect pulmonary function after lung metastasectomy? Eur J Cardiothorac Surg (2009) 0.82

Compartmental tongue surgery: Long term oncologic results in the treatment of tongue cancer. Oral Oncol (2011) 0.82

"Salvage" surgery for primary mediastinal malignancies: is it worthwhile? J Thorac Oncol (2008) 0.81

Rituximab and subcutaneous cladribine in chronic lymphocytic leukemia for newly diagnosed and relapsed patients. Leuk Lymphoma (2010) 0.81

Primary thoracic synovial sarcoma: factors affecting long-term survival. J Thorac Cardiovasc Surg (2007) 0.81

The risk of pneumonectomy over the age of 70. A case-control study. Eur J Cardiothorac Surg (2007) 0.81

Combined small-cell carcinoma of the lung with quadripartite differentiation of epithelial, neuroendocrine, skeletal muscle, and myofibroblastic type. Virchows Arch (2011) 0.81

A critical appraisal of the adjuvant chemotherapy guidelines for patients with completely resected T3N0 non-small-cell lung cancer. Acta Oncol (2010) 0.81

Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications? Ann Thorac Surg (2004) 0.81

Predicting prolonged air leak after standard pulmonary lobectomy: computed tomography assessment and risk factors stratification. Surgeon (2010) 0.80

Study of inorganic particles, fibers, and asbestos bodies by variable pressure scanning electron microscopy with annexed energy dispersive spectroscopy and micro-Raman spectroscopy in thin sections of lung and pleural plaque. Appl Spectrosc (2010) 0.80

Detecting cell-free circulating hTERT mRNA in the plasma may identify a subset of nonsmall cell lung cancer patients. Virchows Arch (2005) 0.80

Growing perivascular epithelioid cell tumor of the liver studied with contrast-enhanced ultrasonography and magnetic resonance imaging. J Ultrasound Med (2008) 0.80

Low-dose CT for quantitative analysis in acute respiratory distress syndrome. Crit Care (2013) 0.80

Anomalous right upper lobe venous drainage. Ann Thorac Surg (2006) 0.80

Anterior approach for Pancoast tumor resection. Multimed Man Cardiothorac Surg (2007) 0.80

A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression. Virchows Arch (2005) 0.79

Synergic approach to XAFS analysis for the identification of most probable binding motifs for mononuclear zinc sites in metalloproteins. J Synchrotron Radiat (2009) 0.79

Langerhans' cell histiocytosis. Lancet (2005) 0.79

Endobronchial tumor embolism. J Bronchology Interv Pulmonol (2013) 0.79

Calcified metastatic mediastinal lymph nodes from mucinous breast adenocarcinoma. Eur Radiol (2003) 0.79

Pulmonary nodules: Contrast-enhanced volumetric variation at different CT scan delays. AJR Am J Roentgenol (2010) 0.79

Environmental manganese compounds accumulate as Mn(II) within the Golgi apparatus of dopamine cells: relationship between speciation, subcellular distribution, and cytotoxicity. Metallomics (2014) 0.78

Does lung cancer screening with low-dose CT remain promising despite disappointing DANTE results? Am J Respir Crit Care Med (2010) 0.78

Ultrasound-guided transcutaneous Tru-Cut biopsy to diagnose laryngopharyngeal masses: a pilot study. Cancer (2007) 0.78

US-guided transcutaneous tru-cut biopsy of laryngo-hypopharyngeal lesions. Eur Radiol (2009) 0.78

Estimating overdiagnosis of lung cancer--reply. Ann Intern Med (2013) 0.78

Adjuvant chemotherapy in new stage II pN0 non-small cell lung cancer: a new issue for a case-by-case decision making process. J Thorac Oncol (2010) 0.78

MR imaging of breast lymphoma. Radiology (2008) 0.78